Japan Facts & Figures Snapshot

Number of consultations for drugs in Japan by category in 2016. Oncology drugs leads the way, followed by gastrointestinal drugs and respiratory tract drugs.


The launch of new medicines for major non-communicable diseases in Japan from 2004-2016 in terms of both applications and approvals.


Regenerative medicine product approvals in Japan between 2014 and 2016.


Regenerative medicine clinical trial consultations in Japan between 2014 and 2016.


Regenerative medicine review times in Japan between 2014 and 2016.

Similar Facts and Figures